Weight Blue Cross and Blue Shield's Federal Employee Program New Research: Tirzepatide in Type 1 Diabetes Tirzepatide is a dual agonist of GLP 1 GIP that is currently FDA approved for glycemic control in type 2 diabetes (MOUNJARO) and weight management (ZEPBOUND). Do you receive CHAMPVA benefits and have other health insurance? Read this. VA News MTG Marvel's Spider Man Limited Set Review: Green TCGplayer Ever feel guilty about how you dispose of your sharps at home? , Meet the simple little device that *snips the needle off* your pen or syringesafe, discreet, and stress free. , Big thanks to Lynn Zepbound Refill Prescription Only (Medication Not Included) BloomMD